Dutasteride Ennogen Ip

Dutasteride Ennogen Ip is a medication used to treat benign prostatic hyperplasia (BPH). This oral tablet helps reduce prostate enlargement symptoms, improving urinary flow and quality of life.

Dutasteride Ennogen Ip is primarily used to manage symptoms of benign prostatic hyperplasia (BPH), a condition where the prostate gland enlarges, causing urinary problems. It works by reducing the size of the prostate, alleviating difficulties such as frequent urination, weak urine stream, and incomplete bladder emptying. This medication is not intended for use in women or children.

Common effects of Dutasteride Ennogen Ip may include reduced prostate size, improved urinary flow, and relief from BPH symptoms. Some users might experience side effects such as dizziness, breast tenderness, or sexual dysfunction. These effects vary and are not universal.

Dutasteride Ennogen Ip should be handled with care. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. This drug is not suitable for everyone, especially those with certain medical conditions or allergies.

Dutasteride Ennogen Ip may interact with other medications, including those metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.